Clincosm LogoSign in Get a demo

Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes

Sponsor
Walter Reed Army Medical Center (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00413751
Collaborator
(none)
20
Enrollment
1
Location

Study Details

Study Description

Brief Summary

The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.

Condition or Disease Intervention/Treatment Phase
  • Drug: Brimonidine tartrate ophthalmic solution 0.15% (Alphagan P)

Study Design

Study Type:
Observational
Time Perspective:
Prospective

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Adult active duty personnel between 18 and 50 years of age with best corrected visual acuity of 20/20 or better.
    Exclusion Criteria:

    • Patients not meeting above stated age criteria

    • Females that are pregnant or lactating (non pregnant females of childbearing potential will have pregnancy test prior to participating in study)

    • History of serious ocular, neurological, cardiovascular disease

    • History of severe systemic disease

    • History of arrhythmias or high blood pressure

    • Patients currently taking any type of ocular or systemic medications except multivitamins.

    • Patients with abnormal pupil shape, Addie's pupil, anisocoria, or abnormal pupil defect.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Walter Reed Army Medical Center Washington District of Columbia United States 20307

    Sponsors and Collaborators

    • Walter Reed Army Medical Center

    Investigators

    • Principal Investigator: KRAIG S. BOWER, MD, Walter Reed Army Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00413751
    Other Study ID Numbers:
    • WRAMC WU #03-23004
    First Posted:
    Dec 20, 2006
    Last Update Posted:
    Dec 20, 2006
    Last Verified:
    Dec 1, 2006
    Keywords provided by , ,
    Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia
    Additional relevant MeSH terms:
    Brimonidine Tartrate
    Ophthalmic Solutions

    Study Results

    No Results Posted as of Dec 20, 2006